Correlation of FOXP3 Expression in Placenta as Regulatory T Cells Marker with Maternal HBeAg Serum and Intrauterine Transmission Status

Hepatitis B is an infectious disease caused by the Hepatitis B Virus (HBV) with a risk of transplacental (mother-to-child) transmission which is responsible for the failure of child

[1]  Yan Wang,et al.  Forkhead box P3 is selectively expressed in human trophoblasts and decreased in recurrent pregnancy loss. , 2019, Placenta.

[2]  S. Demachki,et al.  The −3279C>A and −924A>G polymorphisms in the FOXP3 Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases , 2018, Front. Immunol..

[3]  Setegn Eshetie,et al.  Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission , 2017, Journal of pregnancy.

[4]  D. Dieterich,et al.  Mother-to-child transmission of hepatitis B and C virus: review of the epidemiology and current treatment options , 2018 .

[5]  T. Erkers,et al.  Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy , 2017, Stem cells international.

[6]  N. Trehanpati,et al.  Immune balance in Hepatitis B Infection: Present and Future Therapies , 2017, Scandinavian journal of immunology.

[7]  A. Vallinoto,et al.  Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis , 2017, Front. Immunol..

[8]  F. Kung,et al.  Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area , 2017, Scientific Reports.

[9]  Wei Li,et al.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression , 2016, Chronic diseases and translational medicine.

[10]  M. Voiculescu.  How Far we are towards Eradication of HBV Infection. , 2015, Journal of gastrointestinal and liver diseases : JGLD.

[11]  Ying-ren Zhao,et al.  An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother , 2015, Human vaccines & immunotherapeutics.

[12]  M. Buti,et al.  Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials , 2015, PloS one.

[13]  M. Afrakhteh,et al.  Hepatitis B and pregnancy: An update review article , 2015 .

[14]  G. Cao,et al.  Is mother-to-infant transmission the most important factor for persistent HBV infection? , 2015, Emerging Microbes & Infections.

[15]  Noele P. Nelson,et al.  Prevention of Perinatal Hepatitis B Virus Transmission. , 2014, Journal of the Pediatric Infectious Diseases Society.

[16]  S. Way,et al.  Regulatory T cells and the immune pathogenesis of prenatal infection. , 2013, Reproduction.

[17]  S. Sarin,et al.  Immunological mechanisms of hepatitis B virus persistence in newborns , 2013, The Indian journal of medical research.

[18]  Jianhua Xiao,et al.  Correction: Foxp3 (−/ATT) Polymorphism Contributes to the Susceptibility of Preeclampsia , 2013, PLoS ONE.

[19]  S. Sarin,et al.  Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus‐positive newborns , 2013, Journal of viral hepatitis.

[20]  Jianhua Xiao,et al.  Foxp3 (−/ATT) Polymorphism Contributes to the Susceptibility of Preeclampsia , 2013, PloS one.

[21]  Risto Fotov,et al.  International Journal of Sciences: Basic and Applied Research (IJSBAR) , 2013 .

[22]  R. Gish,et al.  Chronic Hepatitis B Infection , 2005 .

[23]  H. Poustchi,et al.  Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention , 2011, Middle East journal of digestive diseases.

[24]  T. Tran.  Immune tolerant hepatitis B: a clinical dilemma. , 2011, Gastroenterology & hepatology.